Zhang et al43 reported the lack of CCND1 was associated with a compensatory upregulation of CCND3 and the inhibition of both CCND1 and CCND3 could be a suitable strategy for breast cancer prevention and therapy. This evidence concerns the gene CCND3 and breast cancer.